Category: News

Precision Medicine - Biomarkers & Diagnostics

Acobiom announces the CE marking of GemciTest®

GemciTest®, an in-vitro diagnostic that predicts the patient’s response to one of the therapies used to treat pancreatic cancer, is now CE marked, which means it complies with current European regulations in force. Montpellier, France, November 21, 2019. Acobiom develops innovative blood diagnostics in the field of precision medicine. These tests, based on liquid biopsies…
Read more

World Pancreatic Cancer Day 2019 Banner

World Pancreatic Cancer Day 2019

On next November 21, 2019, the World Pancreatic Cancer Day 2019 will be organized. Key information about pancreatic cancer Pancreatic cancer is one of the world’s deadliest cancers. This cancer develops when cells of the organs grow out of control, developing a tumor. The pancreas is a gland located deep in the abdomen, between the…
Read more

How Artificial Intelligence can help to the devlopment of diagnostics dedicated to Precision Medicine

How Artificial Intelligence can help to the development of diagnostics dedicated to Precision Medicine

Generating sequencing data from patient blood samples became easy to perform in clinical trials. But, analyzing the huge amount of genomic or transcriptomic data and extracting the key biomarkers associated with a clinical response to a specific therapy needs a tremendous combination of a scientific expertise, a biomolecular know-how, and a panel of bioinformatics and…
Read more